Autolus Therapeutics (AUTL) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$79.1 million.
- Autolus Therapeutics' Profit After Tax rose 363.22% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 1681.34%. This contributed to the annual value of -$220.7 million for FY2024, which is 590.21% down from last year.
- Per Autolus Therapeutics' latest filing, its Profit After Tax stood at -$79.1 million for Q3 2025, which was up 363.22% from -$47.9 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Profit After Tax ranged from a high of $45.8 million in Q3 2023 and a low of -$242.5 million during Q4 2021
- Over the past 5 years, Autolus Therapeutics' median Profit After Tax value was -$42.1 million (recorded in 2022), while the average stood at -$39.0 million.
- Per our database at Business Quant, Autolus Therapeutics' Profit After Tax surged by 8889.23% in 2022 and then tumbled by 27906.61% in 2024.
- Over the past 5 years, Autolus Therapeutics' Profit After Tax (Quarter) stood at -$242.5 million in 2021, then skyrocketed by 88.89% to -$26.9 million in 2022, then tumbled by 186.53% to -$77.2 million in 2023, then surged by 64.24% to -$27.6 million in 2024, then crashed by 186.66% to -$79.1 million in 2025.
- Its Profit After Tax was -$79.1 million in Q3 2025, compared to -$47.9 million in Q2 2025 and -$70.2 million in Q1 2025.